You are here

  • Home
  • Archive
  • Volume 76, Issue Suppl 2
  • THU0691 Is serum amyloid a protein an useful biomarker to monitor treatment with anti-tumour necrosis factor-alpha agents in spondyloarthritis patients?

Article metrics

Article menu

Download PDFPDF

Poster Presentations
Validation of outcome measures and biomarkers
THU0691 Is serum amyloid a protein an useful biomarker to monitor treatment with anti-tumour necrosis factor-alpha agents in spondyloarthritis patients?
Free

 

Online download statistics by month:

Online download statistics by month: June 2017 to August 2024

AbstractFullPdf
Jun 2017401
Jul 20171800
Aug 2017801
Sep 2017801
Oct 20171203
Nov 20171401
Dec 20171000
Jan 20181803
Feb 20181800
Mar 20182201
Apr 20182400
May 2018400
Jun 20181201
Jul 2018200
Aug 2018600
Oct 2018208
Nov 2018203
Dec 2018601
Jan 2019401
Feb 2019401
Mar 2019004
Apr 2019102
May 2019003
Jun 2019201
Jul 2019202
Aug 2019403
Oct 2019304
Nov 2019101
Feb 2020001
Mar 2020001
Apr 2020100
May 2020001
Jun 2020403
Jul 2020602
Aug 2020001
Sep 20201001
Oct 2020202
Nov 2020200
Dec 2020301
Jan 2021201
Feb 2021002
Apr 2021601
May 2021103
Jun 2021004
Jul 2021101
Aug 2021004
Sep 2021005
Oct 20212016
Nov 20217016
Dec 20211203
Jan 20221202
Feb 2022200
Mar 20221403
Apr 2022201
May 20221009
Jun 20221803
Jul 20221001
Aug 2022903
Sep 2022406
Oct 2022904
Nov 2022601
Dec 2022800
Jan 2023202
Feb 2023200
Mar 20231000
Apr 2023001
May 2023002
Jun 2023001
Jul 2023203
Aug 2023402
Sep 2023201
Nov 20232048
Dec 20231000
Jan 2024201
Feb 2024201
Mar 2024206
Apr 2024805
May 2024001
Jun 2024200
Jul 2024001
Aug 2024203
Total4260226